Article Versions Notes

Schmalzbauer BS, Thondanpallil T, Heller G, Schirripa A, Sperl C-M, Mayer IM, Knab VM, Nebenfuehr S, Zojer M, Mueller AC, et al. CDK6 Degradation Is Counteracted by p16^INK4A and p18^INK4C in AML. Cancers. 2022; 14(6):1554. https://doi.org/10.3390/cancers14061554

Schmalzbauer, Belinda S., Teresemary Thondanpallil, Gerwin Heller, Alessia Schirripa, Clio-Melina Sperl, Isabella M. Mayer, Vanessa M. Knab, Sofie Nebenfuehr, Markus Zojer, André C. Mueller, and et al. 2022. "CDK6 Degradation Is Counteracted by p16^INK4A and p18^INK4C in AML" Cancers 14, no. 6: 1554. https://doi.org/10.3390/cancers14061554

Schmalzbauer, B. S., Thondanpallil, T., Heller, G., Schirripa, A., Sperl, C.-M., Mayer, I. M., Knab, V. M., Nebenfuehr, S., Zojer, M., Mueller, A. C., Fontaine, F., Klampfl, T., Sexl, V., & Kollmann, K. (2022). CDK6 Degradation Is Counteracted by p16^INK4A and p18^INK4C in AML. Cancers, 14(6), 1554. https://doi.org/10.3390/cancers14061554